In shutdown of gene therapy manufacturing facility, Astellas closes Bay Area biotech chapter

Audentes, which Astellas bought four years ago for $3 billion, converted an old warehouse in South San Francisco to handle its gene therapy manufacturing.
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks